Adenylate cyclase-activating polypeptide 1 gene methylation predicts prognosis and the immune microenvironment of bladder cancer

Clin Transl Med. 2021 Oct;11(10):e597. doi: 10.1002/ctm2.597.

Authors

Wenhao Xu¹, Aihetaimujiang Anwaier¹, Wangrui Liu¹, Xi Tian¹, Yuanyuan Qu¹, Jianyuan Zhao², Hailiang Zhang¹, Dingwei Ye¹

Affiliations

¹ Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, P.R. China.
² State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200438, P.R. China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Methylation
Pituitary Adenylate Cyclase-Activating Polypeptide / genetics
Pituitary Adenylate Cyclase-Activating Polypeptide / immunology*
Pituitary Adenylate Cyclase-Activating Polypeptide / metabolism*
Predictive Value of Tests
Prognosis
Tumor Microenvironment / genetics
Tumor Microenvironment / immunology*
Urinary Bladder Neoplasms / genetics
Urinary Bladder Neoplasms / immunology*
Urinary Bladder Neoplasms / metabolism*

Substances

ADCYAP1 protein, human
Pituitary Adenylate Cyclase-Activating Polypeptide